Acquisition of BSV to aid future growth of Mankind Pharma: V-C Juneja - Business Standard

Retrieved on: 2024-08-04 20:09:11

Tags for this article:

Click the tags to see associated articles and topics

Acquisition of BSV to aid future growth of Mankind Pharma: V-C Juneja - Business Standard. View article details on hiswai:

Summary

The article details Mankind Pharma's Rs 13,630 crore acquisition of Bharat Serums and Vaccines (BSV), aligning with the key concept of 'Woman health.' Rajeev Juneja emphasized how this deal enhances Mankind's portfolio in women's health, fertility, and critical care, reflecting the tags 'Mankind Pharma,' 'Vaccine,' and 'Rajeev Juneja.'

Article found on: www.business-standard.com

View Original Article